InvestorsHub Logo
icon url

Alleyba1

04/19/14 12:54 PM

#17312 RE: martin33 #17311

Alleyba says..................

.....that he expresses same sentiments as Martin. It was one of 2 things....selling by Ironridge, selling by shareholders not happy with 10-K, but one thing is clear new blood came into the stock so hopefully we have a new base to work from as we move up. In my opinion, the 10-K came out with all the laundry (which we knew what not be great), but yet the stock closed UP for the week. It also helped crystallize that the main revenue stream will be to develop the niche compounding drugs, ramp up Rapi-meds, and to further expand and develop the sale of generic and controlled substance drugs through the entry of additional states. This is not new information I am putting on here....this has been what the longs have been saying all along.
For those of you who were looking for a short term play we have always said this is long term. I HOPE it was Iron Ridge that cleaned itself out.......but now we have new blood in the stock. Some big blocks went at the end of the day
icon url

coolerheadsprevail

04/20/14 11:26 PM

#17330 RE: martin33 #17311

Let's hope the seller was ironridge.


LOL, the core promoters can stop with the Ironridge ruse now that the 10K is out. Anyone who understands how financiers operate can see by the volume and price action of even just the past couple of weeks that Ironridge is no longer in the picture -- rather, new kids who are equally motivated to sell have jumped into the sandbox to play. Who exactly they are on a day to day basis is impossible to say with any certainty, but the 10K tells us this:

LIST OF NEW DILUTIVE STOCK ISSUANCES

In October, November and December 2013, we issued an aggregate of 62,250 restricted shares of common stock to a note holder as payment of royalties due under the note. The royalty payment was in the amount of $8,798.

In October, November and December 2013, we issued an aggregate of 1,003,442 restricted shares of common stock to Vista Capital Investments, LLC for the conversion of an aggregate of $163,960 in principal amount of a convertible note held by Vista Capital Investments.

In October, November and December 2013, we issued an aggregate of 827,926 restricted shares of common stock to GEL Properties, LLC for the conversion of an aggregate of $140,717 in principal amount of a convertible note held by GEL Properties.

On October 7, 2013 and November 21, 2013, we issued an aggregate of 24,444 restricted shares of common stock to Nick Torrens under a consulting agreement with regard to public relations services. The shares were valued at $3,289.

On October 15, 2013, we issued an aggregate of 1,000,000 restricted shares of common stock to Black Cat Consulting, Inc. under a consulting agreement with regard to investor relations services. The shares were valued at $140,000.

On October 16, 2013, we issued an aggregate of 32,000 restricted shares of common stock to our directors for their attendance at board and/or committee meetings. We took a charge of $5,440 for the issuance of these shares.


On October 29, 2013 and November 14, 2013, we issued an aggregate of 597,756 restricted shares of common stock to IBC Funds LLC for the conversion of an aggregate of $165,288 in principal amount of a convertible note held by IBC Funds.

On December 4, 2013, we issued 841,426 shares of restricted common stock to Seaside 88, LP pursuant to a Stock Purchase Agreement entered into on November 4, 2013. The purchase price of the shares was $88,374.

On December 16, 2013, we issued 313,479 restricted shares of common stock to Redwood Management LLC for the conversion of $40,752 in principal amount of a convertible note held by Redwood Management.

On December 16, 2013, we issued 250,000 restricted shares of common stock to Sean Fitzgibbons under a consulting agreement with regard to investor relations services. These shares were valued at $32,500.

On December 18, 2013, we issued 738,071 restricted shares of common stock to Caesar Capital Group LLC for the conversion of $88,569 in principal amount of a convertible note held by Caesar Capital Group.

On December 23, 2013, we issued an aggregate of 20,000 restricted shares of common stock to our directors for their attendance at board and/or committee meetings. We took a charge of $2,800 for the issuance of these shares.

On December 27, 2013, we issued 498,647 restricted shares of common stock to Group 10 Holdings, LLC for the conversion of $69,811 in principal amount of a convertible note held by Group 10 Holdings.

In January and February 2014 we received cash proceeds of $206,621 from Seaside 88, L.P. for the issuance of an aggregate of 2,270,740 restricted shares of common stock.

From January 1, 2014 until April 10, 2014, we received $1,009,067 in cash in a private subscription sale in which we issued 19,207,420 shares of common stock.

*** END LIST ***

The bolded items at the top represent the restricted shares that unlocked and became free-trading between 4/1/14 and the end of trading last FRI, 4/18/14.

Note the first few entries simply state very broadly that the shares were issued "in October", so we have no idea if it was 10/1 or 10/31. Splitting the baby could reasonably yield an estimate of one-sixth of the total "OCT thru DEC" shares being issued during the first half of OCT (and, therefore, unlocking during the first half of APR). In addition, we can see that 1,000,000 shares belonging to -- let's say it all together now: MORE PAID PROMOTERS -- unlocked and became free-trading on 4/15, which was the exact date that the volume increase began.